| KEGG_PATHWAY |
Cytokine-cytokine receptor interaction |
55 |
1.07E-14 |
| KEGG_PATHWAY |
Graft-versus-host disease |
18 |
8.65E-11 |
| KEGG_PATHWAY |
Allograft rejection |
17 |
2.21E-10 |
| KEGG_PATHWAY |
Type I diabetes mellitus |
18 |
3.59E-10 |
| KEGG_PATHWAY |
Cell adhesion molecules (CAMs) |
31 |
1.18E-09 |
| KEGG_PATHWAY |
Toll-like receptor signaling pathway |
26 |
4.72E-09 |
| KEGG_PATHWAY |
Natural killer cell mediated cytotoxicity |
29 |
2.65E-08 |
| KEGG_PATHWAY |
Hematopoietic cell lineage |
22 |
1.09E-07 |
| KEGG_PATHWAY |
Chemokine signaling pathway |
34 |
1.38E-07 |
| KEGG_PATHWAY |
Antigen processing and presentation |
21 |
2.78E-07 |
| KEGG_PATHWAY |
Viral myocarditis |
19 |
4.93E-07 |
| KEGG_PATHWAY |
Intestinal immune network for IgA production |
15 |
2.01E-06 |
| KEGG_PATHWAY |
Autoimmune thyroid disease |
14 |
1.85E-05 |
| KEGG_PATHWAY |
Systemic lupus erythematosus |
20 |
2.03E-05 |
| KEGG_PATHWAY |
Jak-STAT signaling pathway |
26 |
2.49E-05 |
| KEGG_PATHWAY |
Complement and coagulation cascades |
16 |
3.35E-05 |
| KEGG_PATHWAY |
NOD-like receptor signaling pathway |
15 |
3.91E-05 |
| KEGG_PATHWAY |
Cytosolic DNA-sensing pathway |
13 |
1.98E-04 |
| KEGG_PATHWAY |
T cell receptor signaling pathway |
19 |
2.27E-04 |
| KEGG_PATHWAY |
Primary immunodeficiency |
10 |
3.42E-04 |
| KEGG_PATHWAY |
Leukocyte transendothelial migration |
19 |
6.92E-04 |
| KEGG_PATHWAY |
ECM-receptor interaction |
14 |
0.003302 |
| KEGG_PATHWAY |
B cell receptor signaling pathway |
11 |
0.025533 |
| KEGG_PATHWAY |
Fc gamma R-mediated phagocytosis |
12 |
0.049062 |
